What is NDC 51407-926?

51407-926 is the product NDC for Methylphenidate Hydrochloride, Methylphenidate hydrochloride 36 mg/1 tablet, extended release, listed with the FDA by Golden State Medical Supply, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Golden State Medical Supply, Inc., NDC labeler code 51407. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Methylphenidate Hydrochloride?

148 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Methylphenidate Hydrochloride NDC 51407-926

NDC codes

FDA NDC Directory

Product NDC (as listed)51407-926Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51407-0926Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51407-926-01	5140709260151407092601	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51407-926-01)Marketed from Jun 21, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methylphenidate Hydrochloride
Generic name (nonproprietary): methylphenidate hydrochloride
Active ingredients: Methylphenidate hydrochloride — 36 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Golden State Medical Supply, Inc.NDC labeler code 51407
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205327
Marketing start: Jul 28, 2017
Listing expires: Dec 31, 2027
DEA schedule: CII
Other FDA classes: Central Nervous System Stimulation (Physiologic effect)
Identifiers: Product ID 51407-926_50289734-e08d-0f5a-e063-6394a90ab421SPL ID 50289734-e08d-0f5a-e063-6394a90ab421SPL set ID 22e5ddfa-7264-fbb1-e063-6394a90a6483RxCUI 1091155, 1091170, 1091185, 1091210UNII 4B3SC438HI
Pharmacologic class: Central Nervous System Stimulant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451407092601 followed by a unit qualifier and the quantity

Package 51407-0926-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 23, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Methylphenidate hydrochloride extended-release tablets are indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in patients aged 6 to 65 years old. Limitations of Use The use of methylphenidate hydrochloride extended-release tablets is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions ( 5.7 ), and Use in Specific Populations ( 8.4 )]. Methylphenidate hydrochloride extended-release tablets are a CNS stimulant indicated for the treatment of attention deficit hyperactivit…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51407-926

What is NDC 51407-926?: 51407-926 is the product NDC for Methylphenidate Hydrochloride, Methylphenidate hydrochloride 36 mg/1 tablet, extended release, listed with the FDA by Golden State Medical Supply, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Methylphenidate Hydrochloride.
What is the active ingredient?: Methylphenidate hydrochloride.
Who is the labeler?: Golden State Medical Supply, Inc., NDC labeler code 51407. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Methylphenidate Hydrochloride?: 148 other product NDCs are listed under this name. See all Methylphenidate Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Methylphenidate Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 72 mg/1	Tablet, Extended releaseOral	Northstar Rx LLC	72603-399	72603-0399-01
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 72 mg/1	Tablet, Extended releaseOral	Sun Pharmaceutical Industries, Inc.	57664-710	57664-0710-8357664-0710-88
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 10 mg/1	TabletOral	Bryant Ranch Prepack	71335-2968	71335-2968-01
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 5 mg/1	TabletOral	Bryant Ranch Prepack	72162-2428	72162-2428-01
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 10 mg/1	TabletOral	Bryant Ranch Prepack	72162-2429	72162-2429-01
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 20 mg/1	TabletOral	Bryant Ranch Prepack	72162-2430	72162-2430-01
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 5 mg/1	TabletOral	Nivagen Pharmaceuticals, Inc.	75834-324	75834-0324-01
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 10 mg/1	TabletOral	Nivagen Pharmaceuticals, Inc.	75834-325	75834-0325-01
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 20 mg/1	TabletOral	Nivagen Pharmaceuticals, Inc.	75834-326	75834-0326-01
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 63 mg/1	Tablet, Extended releaseOral	Trigen Laboratories, LLC	13811-700	13811-0700-30

All 149 Methylphenidate Hydrochloride NDCs

Other NDCs under ANDA 205327

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205327
Product	Strength	Form · route	Labeler	Product NDC
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 18 mg/1	Tablet, Extended releaseOral	Trigen Laboratories, LLC	13811-706
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 27 mg/1	Tablet, Extended releaseOral	Trigen Laboratories, LLC	13811-707
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 36 mg/1	Tablet, Extended releaseOral	Trigen Laboratories, LLC	13811-708
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 54 mg/1	Tablet, Extended releaseOral	Trigen Laboratories, LLC	13811-709
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 72 mg/1	Tablet, Extended releaseOral	Trigen Laboratories, LLC	13811-710
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 18 mg/1	Tablet, Extended releaseOral	Golden State Medical Supply, Inc.	51407-924
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 27 mg/1	Tablet, Extended releaseOral	Golden State Medical Supply, Inc.	51407-925
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 54 mg/1	Tablet, Extended releaseOral	Golden State Medical Supply, Inc.	51407-927